BP000233-CYT-060: Recombinant Human Oncostatin-M (OSM) Protein, His Tag
Source: E. coli-derived.
Purity: > 95% by SDS-PAGEBP002923-PRO-889: Recombinant Human Orosomucoid 1 (ORM1) Protein
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.BP002925-PRO-1200: Recombinant Human Ornithine decarboxylase antizyme 1 (OAZ1) Protein
Source: E. coli-derived.
Purity: >90.0% as determined by SDS-PAGE.BP002927-PRO-844: Recombinant Human Nuclear transport factor 2 (NUTF2) Protein
Source: E. coli-derived.
Purity: >95.0% as determined by SDS-PAGE.BP002383-PKA-363: Recombinant Human Non-Metastatic Cells 2 (NME2) Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP002527-ENZ-220: Recombinant Human Nei Endonuclease VIII-Like 1 (NEIL1) Enzyme
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.BP000258-CYT-284: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells (PAE/FLT -4 cells). The ED50 for this effect is typically 150-300 ug/ml, corresponding to a specific activity of 3.3-6.6 KUnits/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-262: Recombinant Rat Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to stimulate phosphorylation of the VEGFR-3/FLT-4 receptor in porcine aortic endothelial cells. The ED50 for this effect is typically 200-300 ug/ml corresponding to a Specific Activity of 3,334-5,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000258-CYT-527: Recombinant Human Vascular Endothelial Growth Factor C (VEGF-C) Protein
Source: Sf9, Insect Cells-derived.
Measured by its ability to bind to the VEGFR-3/FLT-4 receptor in the Ba/F3-hVEGFR-3 assay. The ED50 in this assay is about 4 ug/ml corresponding to a Specific Activity of 250,000 IU/mg.
Purity: > 90% by SDS-PAGE and RP-HPLC.BP000027-CYT-241: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1-8 ug/ml corresponding to a Specific Activity of 125,000-1,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.